Shareholding disclosure

Cosmo Pharmaceuticals S. p.A

Declared position

98.96%

Threshold

Crossed upwards

Timeline

Published

11.03.2010

Transaction

26.02.2010

Transfer date

04.03.2010

Voting rights breakdown

Voting rights acquired98.96%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAA3A00030

Beneficial owner

Cosmo Pharmaceuticals S. p.A

Declared address

Cosmo Pharmaceuticals S. p.A., 20020 Lainate (MI)

Finalization of public tender offer

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Cosmo Pharmaceuticals S. p.A

BioXell S.p.A.11.03.2010TAA3A00030

Disclosure summary

Cosmo Pharmaceuticals S. p.A disclosed a holding in BioXell S.p.A. on the acquisition side, published by SIX Exchange Regulation on 11.03.2010, at 98.96% of voting rights. Notice category: Single shareholder.

Disclosed position

98.96%

Voting rights acquired

Voting rights acquired98.96%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Cosmo Pharmaceuticals S. p.A disclosed a holding in BioXell S.p.A., published on 11.03.2010.

Publication date11.03.2010

Transaction date26.02.2010

Transfer date04.03.2010

Issuing companyBioXell S.p.A.

Beneficial ownerCosmo Pharmaceuticals S. p.A

Declared addressCosmo Pharmaceuticals S. p.A., 20020 Lainate (MI)

CategorySingle shareholder

Voting rights acquired98.96%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAA3A00030

Conditions

Finalization of public tender offer

Source: SIX Exchange Regulation · Publication date: 11.03.2010

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open